معرفی
Tom Stargardt is a Professor of Health Care Management at the Hamburg Center for Health Economics, University of Hamburg. His research focuses on health economics, pharmaceutical policy, and healthcare system efficiency. He holds a Dr. rer. oec. from TU Berlin (2008) and has held academic positions including Junior Professor for Pharmacoepidemiology at the University of Hamburg and a postdoctoral fellowship at LMU Munich and Helmholtz Zentrum München. His work spans cost-effectiveness analyses of treatments, health technology assessment, and pandemic-related behavioral economics. He has been recognized with the 2009 Nachwuchspreis for health economics/politics and a 2007 Merck-funded stipend.
Research interests include pharmaceutical market dynamics, telemedicine cost-benefit analyses, and socioeconomic disparities in healthcare access. He has authored over 100 publications on topics like drug pricing regulations, vaccine hesitancy, and pandemic policy responses. His current projects analyze healthcare system efficiency during crises and the impact of digital health interventions. He is affiliated with the Hamburg Center for Health Economics and serves on editorial boards for journals like Pharmacoeconomics and Health Economics.
- Educations: TU Berlin (PhD 2008, Diplom 2005)
- Key Awards: Progenerika Early Career Prize (2009), Merck Stipend (2007)
- Professional Memberships: Verein für Socialpolitik, International Health Economics Association
His advisory work includes evaluations of disease management programs and health policy reforms. Recent grants focus on pandemic healthcare economics and biosimilar market dynamics. He leads research teams investigating cost-utility of innovative cancer therapies and digital health solutions for chronic disease management.
